Search

everythinglearnresearchcommunity

for

Search:↓

Younger patients and those with more hair loss are less likely to benefit from oral steroid treatment for hair loss, and low vitamin D may predict relapse.

Some breast cancer chemotherapy can cause permanent hair loss.

New and existing treatments for hair loss show promise, with some being more effective for men and others for women.

Combining corticosteroids and minoxidil can quickly regrow hair lost from radiation.

Biotin supplements increased biotin levels but did not significantly prevent hair loss in rats on valproic acid.

RF-mesotherapy with bicalutamide may be a promising new treatment for hair loss.

Intradermal dutasteride effectively and safely improves hair growth in early-stage androgenetic alopecia.

Yoga Prana Vidya healing can effectively treat hair loss in children.

Baricitinib effectively reduces hair loss in alopecia areata and is well-tolerated.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Chemotherapy with carboplatin-paclitaxel causes hair loss in all patients.

Doxycycline can effectively treat hair loss caused by EGFR inhibitors.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

PUVA treatment is generally ineffective for alopecia areata.

Androgen deprivation therapy might help prevent severe COVID-19, but more research is needed.

Various skin conditions can be treated effectively with different methods, such as discontinuing certain drugs, using specific vaccines, applying creams, and changing lifestyle habits like smoking and drinking.

Adding stromal vascular fraction to platelet-rich plasma injections did not significantly improve hair growth in androgenetic alopecia treatment.

Some hair loss from medication may reverse after stopping the drug, but treatment options are limited and ongoing research is needed.

Azelaic acid and finasteride can help preserve skin flaps after surgery by increasing BCL-2 protein and decreasing bax protein.

Bicalutamide does not significantly affect liver enzymes and is a safe anti-androgen option for transfeminine individuals.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

A new mix of anthralin and calcipotriene might help treat severe hair loss.

Intensive immunosuppression can reduce relapse rates in multiple sclerosis patients, despite some side effects.

Chemotherapy and radiotherapy improved quality of life and reduced symptoms in lung cancer patients.

Simvastatin/ezetimibe may help treat new cases of alopecia areata but not long-term cases.

A woman lost her hair after taking acyclovir, but it grew back when she stopped the medication.

Platelet-rich plasma therapy may help treat folliculitis decalvans but benefits might not last without ongoing treatment.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Combining delgocitinib ointment with excimer laser can effectively treat severe alopecia areata.